Silverarc Capital Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.36M | Buy |
+287,796
| New | +$9.36M | 1.73% | 18 |
|
|
2025
Q1 | – | Sell |
-40,788
| Closed | -$3.34M | – | 75 |
|
|
2024
Q4 | $3.34M | Sell |
40,788
-19,712
| -33% | -$1.61M | 0.73% | 37 |
|
|
2024
Q3 | $6.91M | Buy |
60,500
+58,000
| +2,320% | +$6.63M | 1.55% | 19 |
|
|
2024
Q2 | $189K | Buy |
+2,500
| New | +$189K | 0.04% | 65 |
|
|
2023
Q1 | – | Sell |
-83,135
| Closed | -$3.99M | – | 86 |
|
|
2022
Q4 | $3.99M | Buy |
+83,135
| New | +$3.99M | 1.14% | 32 |
|